Literature DB >> 7779706

Variation of growth rate of a rat tumour during a light-dark cycle: correlation with circadian fluctuations in tumour blood flow.

K Hori1, Q H Zhang, H C Li, S Saito.   

Abstract

To determine whether tumour growth is influenced by circadian variations in tumour tissue blood flow, we measured changes in area doubling time of tumours (Sato lung carcinoma) within transparent chambers and changes in tissue blood flow of rat subcutaneous tumour during a light-dark cycle. Rats were subjected to an artificial light-dark cycle with light from 7 a.m. to 7 p.m. Tumour doubling times (TDTs) during the dark and the light spans were 33.5 +/- 11.9 h (n = 38, 20 rats) and 70.6 +/- 36.9 h (n = 39, 20 rats) respectively. The former was significantly shorter than the latter (P < 0.001). In addition, the larger the tumour became, the longer was the TDT during the light span (P < 0.05). Tumour tissue blood flow during the night (10 p.m.-4 a.m.) was approximately 1.5 times greater than that during the day (10 a.m.-4 p.m.). The time during which tumours actively grow and that during which tissue blood flow in tumours increases coincided. These results strongly suggest that tumour tissue blood flow is a determining influence on tumour proliferative activity and that tumour growth is influenced by circadian variations in tumour tissue blood flow.

Entities:  

Mesh:

Year:  1995        PMID: 7779706      PMCID: PMC2033848          DOI: 10.1038/bjc.1995.227

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

Review 1.  Tumor angiogenesis.

Authors:  J Folkman
Journal:  Adv Cancer Res       Date:  1974       Impact factor: 6.242

2.  Development of the vascular system in the hamster malignant neurilemmoma.

Authors:  H A Eddy; G W Casarett
Journal:  Microvasc Res       Date:  1973-07       Impact factor: 3.514

3.  Changes of histological and proliferative indices in the Walker carcinoma with tumour size and distance from blood vessel.

Authors:  I Brammer; F Zywietz; H Jung
Journal:  Eur J Cancer       Date:  1979-11       Impact factor: 9.162

4.  Enzymorphological observation on irradiated tumor, with a particular reference to acid hydrolase activity. I. Light microscopic study.

Authors:  Y Shimosato; K Watanabe
Journal:  Gan       Date:  1967-12

5.  Circadian variation of tumor blood flow in rat subcutaneous tumors and its alteration by angiotensin II-induced hypertension.

Authors:  K Hori; M Suzuki; S Tanda; S Saito; M Shinozaki; Q H Zhang
Journal:  Cancer Res       Date:  1992-02-15       Impact factor: 12.701

6.  Tumor blood flow: the principal modulator of oxidative and glycolytic metabolism, and of the metabolic micromilieu of human tumor xenografts in vivo.

Authors:  F Kallinowski; K H Schlenger; M Kloes; M Stohrer; P Vaupel
Journal:  Int J Cancer       Date:  1989-08-15       Impact factor: 7.396

7.  Functional characteristics of tumor vessels: selective increase in tumor blood flow.

Authors:  M Suzuki; K Hori; S Saito; S Tanda; I Abe; H Sato; H Sato
Journal:  Sci Rep Res Inst Tohoku Univ Med       Date:  1989-12

8.  In vivo analysis of tumor vascularization in the rat.

Authors:  K Hori; M Suzuki; S Tanda; S Saito
Journal:  Jpn J Cancer Res       Date:  1990-03

9.  Tumor dormancy in vivo by prevention of neovascularization.

Authors:  M A Gimbrone; S B Leapman; R S Cotran; J Folkman
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

10.  Fluctuations in tumor blood flow under normotension and the effect of angiotensin II-induced hypertension.

Authors:  K Hori; M Suzuki; S Tanda; S Saito; M Shinozaki; Q H Zhang
Journal:  Jpn J Cancer Res       Date:  1991-11
View more
  3 in total

1.  Flight capacity drives circadian patterns of metabolic rate and alters resource dynamics.

Authors:  Zachary R Stahlschmidt
Journal:  J Exp Zool A Ecol Integr Physiol       Date:  2022-04-19

2.  A novel combretastatin A-4 derivative, AC7700, strongly stanches tumour blood flow and inhibits growth of tumours developing in various tissues and organs.

Authors:  K Hori; S Saito; K Kubota
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

3.  Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis.

Authors:  K Hori; S Saito
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.